144309-49-9

Basic information

• Product Name: 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)-, (2E)-
• CAS NO: 144309-49-9
• Molecular Formula: C18H18O4
• Molecular Weight: 298.339
• Mol File: 144309-49-9.mol
• Article Data: 11

Chemical Properties

• CAS DataBase Reference: 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)-, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)-, (2E)-(144309-49-9)
• EPA Substance Registry System: 2-Propen-1-one, 3-(3,4-dimethoxyphenyl)-1-(4-methoxyphenyl)-, (2E)-(144309-49-9)

Safety Data

• Hazardous Substances Data: 144309-49-9(Hazardous Substances Data)

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 100-06-1 1-(4-methoxyphenyl)ethanone 
• 6380-23-0 3,4-dimethoxystyrene 
• 696-62-8 para-iodoanisole 
• 82102-37-2 9-methyl-9H-fluorene-9-carbonyl chloride 
• 18414-58-9 diphenylmethylsilanecarboxylic acid 
• 20912-79-2 4-methoxyphenacylidene dimethylsulphurane 

Downstream Products

• 110048-38-9 2-(3,4-dimethoxy-phenyl)-4-(4-methoxy-phenyl)-4-oxo-butyric acid 
• 73910-92-6 2-(4-chloro-phenyl)-4-(3,4-dimethoxy-phenyl)-6-(4-methoxy-phenyl)-pyridine 
• 78121-83-2 4-(3,4-Dimethoxy-phenyl)-2,6-bis-(4-methoxy-phenyl)-pyridine 
• 109614-10-0 2-(3,4-dimethoxy-phenyl)-4-(4-methoxy-phenyl)-4-oxo-butyronitrile 
• 111797-28-5 2-(3,4-dimethoxy-phenyl)-4-(4-methoxy-phenyl)-4-oxo-butyric acid methyl ester 
• 1422433-38-2 C₂₂H₂₂N₂O₄ 
• 851715-53-2 C₂₄H₂₆O₆ 

Relevant articles and documents

Efficient π-electron conjugated push-pull nonlinear optical chromophore 1-(4-methoxyphenyl)-3-(3,4-dimethoxyphenyl)-2-propen-1-one: A vibrational spectral study

As part of the efforts for the design new organic nonlinear optical (NLO) materials with high efficiency for present day technological requirements, a comprehensive investigation on the intramolecular charge transfer (ICT) of an efficient π-conjugated pot

Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors

Presently, artemisinin-based combination therapy (ACT) is the first-line therapy of Plasmodium falciparum malaria. With the emergence of malaria parasites that are resistant to ACT, alternative antimalarial therapies are urgently needed. In line with this

Synthesis and cytotoxic evaluation of alkoxylated chalcones

A series of chalcones a1-20 bearing a 4-OMe groups on the A-ring were initially synthesized and their anticancer activities towards HepG2 cells evaluated. Subsequently, a series of chalcones b1-42 bearing methoxy groups at the 2′ and 6′-positions of the B-ring were synthesized and their anticancer activities towards five human cancer cell lines (HepG2, HeLa, MCF-7, A549 and SW1990) and two non-tumoral human cell lines evaluated. The results showed that six compounds (b6, b8, b11, b16, b18, b22, b23 and b29) displayed promising activities, with compounds b22 and b29 in particular showing higher levels of activity than etoposide against all five cancer cell lines. Compound b29 showed a promising SI value compared with both HMLE and L02 (2.1-6.5 fold in HMLE and > 33 > 103.1 fold in L02, respectively).